D
Daniela Matarrese
Publications - 16
Citations - 718
Daniela Matarrese is an academic researcher. The author has contributed to research in topics: Medicine & Diabetes mellitus. The author has an hindex of 6, co-authored 15 publications receiving 485 citations.
Papers
More filters
Journal ArticleDOI
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact.
Fabrizio Cantini,Laura Niccoli,Daniela Matarrese,Emanuele Nicastri,Paolo Stobbione,Delia Goletti +5 more
TL;DR: Graphical abstract Image, graphical abstract images showing how the model transformed from a discrete-time model to a 3D model with real-time consequences has changed over time.
Journal ArticleDOI
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality.
Justin Stebbing,Ginés Sánchez Nievas,Marco Falcone,Sonia Youhanna,Peter D. Richardson,Silvia Ottaviani,Joanne X. Shen,Christian Sommerauer,Giusy Tiseo,Lorenzo Ghiadoni,Agostino Virdis,Fabio Monzani,Luis Romero Rizos,Francesco Forfori,Almudena Avendaño Céspedes,Salvatore De Marco,Laura Carrozzi,Fabio Lena,Pedro Manuel Sánchez-Jurado,Leonardo Gianluca Lacerenza,Nencioni Cesira,David Caldevilla Bernardo,Antonio Perrella,Laura Niccoli,Lourdes Sáez Méndez,Daniela Matarrese,Delia Goletti,Yee-Joo Tan,Vanessa Monteil,George Dranitsaris,Fabrizio Cantini,Alessio Farcomeni,Shuchismita Dutta,Stephen K. Burley,Haibo Zhang,Mauro Pistello,William W. Li,Marta Mas Romero,Fernando Andrés Pretel,Rafaela Sánchez Simón-Talero,Rafael García-Molina,Claudia Kutter,James H. Felce,Zehra F. Nizami,Andras G. Miklosi,Josef M. Penninger,Josef M. Penninger,Francesco Menichetti,Ali Mirazimi,Pedro Abizanda,Volker M. Lauschke +50 more
TL;DR: It is found that baricitinib exerts activity rapidly through the inhibition of host proteins (numb-associated kinases), uniquely among antivirals, and is associated with beneficial outcomes including in severely ill elderly patients, data that incentivize further randomized controlled trials.
Journal ArticleDOI
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.
Fabrizio Cantini,Laura Niccoli,Carlotta Nannini,Daniela Matarrese,Massimo Edoardo Di Natale,Pamela Lotti,D. Aquilini,Giancarlo Landini,Barbara Cimolato,Massimo Di Pietro,Michele Trezzi,Paolo Stobbione,Gabriele Frausini,Assunta Navarra,Emanuele Nicastri,Giovanni Sotgiu,Delia Goletti +16 more
TL;DR: Baricitinib, an anti-JAK1/JAK2, reduces cytokine release and SARS-Co-V2 entry and reduces COVID-19 mortality rate in a retrospective multicenter study and reduces intensive care unit admissions of CO VID-19 pneumonia.
Journal ArticleDOI
In Hospital and 3-Month Mortality and Functional Recovery Rate in Patients Treated for Hip Fracture by a Multidisciplinary Team.
Carlo Rostagno,Roberto Buzzi,Domenico Andrea Campanacci,Alberto Boccacini,Alessandro Cartei,Gianni Virgili,Andrea Belardinelli,Daniela Matarrese,Andrea Ungar,Martina Rafanelli,Roberto Gusinu,Niccolò Marchionni +11 more
TL;DR: Identification and stabilization of concomitant clinical problems by internal medicine specialists may safely decrease time to surgery in frail subjects with hip fracture and integrate perioperative clinical management may shorten hospital stay with no apparent increase in in-hospital mortality and ultimately improve the outcome.
Journal ArticleDOI
Impact of Chronic Care Model on diabetes care in Tuscany: a controlled before-after study
Valentina Barletta,Francesco Profili,Rosa Gini,Leonardo Grilli,Carla Rampichini,Daniela Matarrese,Paolo Francesconi +6 more
TL;DR: The first year of the CCM implementation had a significant impact on the diabetes care indicator, and performance was stabilized after the first year, while impact on therapy indicator was smaller.